ClinicalTrials.govpublic full text
To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes
non-alcoholic steatohepatitis, type2 diabetes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 152373
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.